Clinical Trial Update: Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether adding prazosin to peg-interferon alfa-2b and ribavirin improves efficacy in chronic hepatitis C with genotypes 1 or 4 and seve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Fibrosis

Drugs mentioned

• Peginterferon alfa-2b (Peginterferon alfa-2b)
• Prazosin (prazosin)
• Ribavirin (ribavirin)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Hepatitis C, Chronic, Fibrosis | Phase 2 | Status: UNKNOWN